CLINICAL_TRIALS
trial_result
· 2013-06-26
Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating paclitaxel for recurrent or progressive advanced ovarian cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED